Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: A randomized, multicenter study with 4-year follow-up

Texas Heart Institute Journal

Volumn 31, Issue 3, 2004, Pages 231-239

  Frazier, O H ^a   Tuzun, Egemen ^a   Eichstadt, Harald ^a   Boyce, Steven W ^b   Lansing, Allan M ^c   March, Robert J ^d   Sartori, Michele ^a   Kadipasaoglu, Kamuran A ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c Norton Audubon Hospital   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angina pectoris classification surgery; Cohort studies; Coronary artery bypass; Coronary disease surgery mortality; Laser surgery instrumentation methods mortality; Lasers therapeutic use; Myocardial revascularization; Survival analysis; Treatment outcome

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; INSTRUMENTATION; LASER SURGERY; MALE; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ASSISTED CIRCULATION; COMBINED MODALITY THERAPY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 4444367919     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score [published erratum appears in JAMA 1992;268:1860]. JAMA 1992;267:2344-8.
2. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score [published erratum appears in JAMA 1992;268:1860]. JAMA 1992;267:2344-8.
3. Bell MR, Gersh BJ, Schaff HV, Holmes DR Jr, Fisher LD, Alderman EL, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992;86:446-57.
4. Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR Jr, Riechwald N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983;51:7-12.
5. Jones EL, Weintraub WS. The importance of completeness of revascularization during long-term follow-up after coronary artery operations. J Thorac Cardiovasc Surg 1996;112:227-37.
6. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997;113:645-54.
7. Allen KB, Dowling RB, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999;341:1029-36.
8. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir M, Barasch E, et al. Myocardial revascularization with laser. Preliminary findings. Circulation 1995;92(9 Suppl):II58-65.
9. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999;341:1021-8.
10. Trehan N, Mishra Y, Mehta Y, Jangid DR. Transmyocardial laser as an adjunct to minimally invasive CABG for complete myocardial revascularization. Ann Thorac Surg 1998;66:1113-8.
11. 2 laser revascularization: a chance for the 'inoperable' patient. Eur J Cardiothorac Surg 1997;11:888-94.
12. Stamou SC, Boyce SW, Cooke RH, Carlos BD, Sweet LC, Corso PJ. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol 2002;89:1365-8.
13. Perin EC, Dohmann HJ, Dohmann HF, de Mattos ND, Carvalho LA. Laser channels after percutaneous transmyocardial revascularization. Circulation 1999;99:2218.
14. Cooley DA, Frazier OH, Kadipasaoglu KA, Pehlivanoglu S, Shannon RL, Angelini P. Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart Inst J 1994;21:220-4.
15. Horvath KA, Smith WJ, Laurence RG, Schoen FJ, Appleyard RF, Cohn LH. Recovery of viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 1995;25:258-63.
16. Allen KB, Dowling RB, DelRossi AJ, Realyvasques F, Lefrak EA, Pfeffer TA, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 2000;119:540-9.
17. Peterson ED, Kaul P, Kaczmarek RG, Hammill BG, Armstrong PW, Bridges CR, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol 2003;42:1611-6.
18. 2 laser. Circulation 2001;104(12 Suppl 1):I81-4.
19. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial [published erratum appears in Lancet 1999;353(9165):1714]. Lancet 1999;353(9152):519-24.
20. Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial [published erratum appears in Lancet 1999;353(9165):1714]. Lancet 1999;353(9152):519-24.
21. Gray TJ, Burns SM, Clarke SC, Tait S, Sharples LD, Caine N, Schofield PM. Percutaneous myocardial laser revascularization in patients with refractory angina pectoris. Am J Cardiol 2003;91(6):661-6.
22. Kadipasaoglu KA, Frazier OH. Transmyocardial laser revascularization: effect of laser parameters on tissue ablation and cardiac perfusion. Semin Thorac Cardiovasc Surg 1999;11:4-11.
23. Spanier T, Smith CR, Burkhoff D. Angiogenesis: a possible mechanism underlying the clinical benefits of transmyocardial laser revascularization. J Clin Laser Med Surg 1997;15:269-73.
24. Kwong KF, Schuessler RB, Kanellopoulos GK, Saffitz JE, Sundt TM 3rd. Nontransmural laser treatment incompletely denervates canine myocardium. Circulation 1998(19 Suppl):II67-72.
25. Leon MB, Baim DS, Moses JW, Laham RJ, Knopf W, Reisman M, et al. A randomized blinded clinical trial comparing percutaneous laser myocardial revascularization (using Biosense LV mapping) vs placebo in patients with refractory coronary ischemia [abstract]. Circulation 2000;102(18 Suppl 2):II565.
26. Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet 1999;354(9182):885-90.
27. Oesterle SN, Sanborn TA, Ali N, Resar J, Ramee SR, Heuser R, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000;356(9243):1705-10.
28. Kadipasaoglu KA, Sartori M, Masai T, Cihan HB, Clubb FJ Jr, Conger JL, Frazier OH. Intraoperative arrhythmias and tissue damage during transmyocardial laser revascularization. Ann Thorac Surg 1999;67(2):423-31.